NCT05362279

Brief Summary

This study was conducted to evaluate the oxygen therapy methods used in pediatric services and to specify the roles and responsibilities of nurses in the application of HFNC, which is one of these methods. Although the decision to implement this treatment method is under the responsibility of the physician in Turkey, the use of the device, observing the effectiveness of the treatment, monitoring and recording the changes in the vital signs of the children are under the responsibility of the nurses shows the importance of the nursing perspective on HFNC.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 5, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

May 10, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2022

Completed
Last Updated

May 5, 2022

Status Verified

May 1, 2022

Enrollment Period

1 month

First QC Date

April 23, 2022

Last Update Submit

May 4, 2022

Conditions

Keywords

HFNCNursing CareKnowledge LevelEducation

Outcome Measures

Primary Outcomes (1)

  • Knowledge Level - Education Form- Questionnaire

    To increase the knowledge level of nurses about oxygen therapy with high flow nasal cannula.

    One month after training

Study Arms (2)

Test after post-test training

EXPERIMENTAL

Pre-test will be applied to the nurses in the experimental group before the training. The post-test will be applied to the experimental group, to which the pre-test was applied, one month after the training was given.

Other: Training

Test without training

NO INTERVENTION

The nurses in the control group are the group to be administered the post-test without any intervention after the pre-test. The post-test will be administered one month after the pre-test.

Interventions

One month after the pre-test, the post-test will be administered to the nurses who will be in the control group. Nurses who will be in the experimental group will be given training after the pre-test. A post-test will be administered one month after the training.

Test after post-test training

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Nurses working in any of the pediatric emergency departments, pediatric clinics
  • No previous training in HFNC treatment
  • Follow-up of patients treated with HFNC
  • Volunteering to participate in research

You may not qualify if:

  • Those who have received in-service training on HFNC implementation
  • Those who work as responsible nurses or training nurses in the clinics where the research will be conducted

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Colleti Junior J, Longui TE, Carvalho WB. HIGH-FLOW NASAL CANNULA POST-TRACHEAL EXTUBATION IN A CHILD WITH UPPER AIRWAY OBSTRUCTION: CASE REPORT. Rev Paul Pediatr. 2018 Jul-Sep;36(3):372-375. doi: 10.1590/1984-0462/;2018;36;3;00010. Epub 2018 Jul 10.

    PMID: 29995143BACKGROUND

Study Officials

  • Aslı ALACA

    Study Principal Investigator

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized controlled study with pretest-posttest experimental and control groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 23, 2022

First Posted

May 5, 2022

Study Start

May 10, 2022

Primary Completion

June 10, 2022

Study Completion

August 10, 2022

Last Updated

May 5, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share